The 5% Problem: The Access Gap Behind GLP-1s, Hormone Therapy, and Midlife Weight Gain What the science actually shows about menopause, metabolism, and GLP-1s - and why the biggest barrier isnt biology, but access to evidence-based care
The 2022 ASMBS/IFSO guidelines state that metabolic and bariatric surgery has extensive evidence for safety, efficacy, and durability, with overall long-term outcomes often exceeding 60% excess weight loss
Mucosal biopsy of a patient with COVID-19 presenting with diarrhea and abdominal pain showed presence of SARS-CoV-2 in endothelial cells by immunochemistry
The Semaglutide programme builds on Gen-Plus's proven experience in oral and transdermal delivery technologies for both small molecules and complex biologics
"The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum"
doi: 10.1016/j.suponc.2012.03.003